Human medicines European public assessment report EPAR Remsima infliximab Arthritis PsoriaticSpondylitis AnkylosingColitis UlcerativePsoriasisCrohn DiseaseArthritis Rheumatoid Date of authorisation 10092013 Revision 18 Status Authorised
↧